Deanna D. Strable-Soethout, Chair, President and CEO, has filed 47 Form 4 transactions across two companies, with a pronounced sell-side bias. Her total open-market sales reached $13.99 million, while she recorded zero open-market purchases. The bulk of her activity centers on Principal Financial Group (PFG), where she executed four open-market sales in January 2026 totaling approximately $2.35 million, with individual transactions ranging from $27,750 on January 8 to $884,616 on January 29. These sales were accompanied by a series of option exercises and share dispositions in June 2026, including exercises valued at $1.06 million and $871,574 on June 12, paired with sales back to the issuer (code D) worth $474,258 and $2.92 million.
The transaction pattern reveals a consistent monetization of equity compensation rather than a directional bet on the stock. Strable-Soethout received multiple grants (code A) with zero value in early 2026, alongside option exercises (code M) that were immediately offset by shares sold back to the issuer (code D) to cover tax obligations. Her only other holding is Elevance Health (ELV), where she received a zero-value grant in May 2026. The absence of any open-market purchases—the only code indicating conviction—combined with the steady stream of sales and automatic tax-related dispositions, suggests a routine liquidation of vested awards. The most recent activity, a pair of zero-value grants on June 26, 2026, does not alter the overall trajectory of net selling.
AI-assisted summary